These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8891452)

  • 1. Hormone replacement therapy and cardiovascular risk in post-menopausal women with NIDDM.
    Sattar N; Jaap AJ; MacCuish AC
    Diabet Med; 1996 Sep; 13(9):782-8. PubMed ID: 8891452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of coronary risk factors in non-insulin dependent (type 2) diabetics.
    Walia M; Agarwal AK; Shah P; Yadav R; Singh CP; Yadav P
    J Assoc Physicians India; 1999 Nov; 47(11):1051-5. PubMed ID: 10862311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F; Gerson M
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Menopause and hormone replacement therapy (HRT) in women with diabetes].
    Cyganek K
    Przegl Lek; 1999; 56(5):362-71. PubMed ID: 10554574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of coronary heart disease in type 2 diabetes.
    Mykkänen L
    Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy: cardiovascular benefits for aging women.
    Sites CK
    Coron Artery Dis; 1998; 9(12):789-93. PubMed ID: 9894922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU; Ridker PM; Manson JE
    Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes.
    Masding MG; Stears AJ; Burdge GC; Wootton SA; Sandeman DD
    Diabet Med; 2006 Jul; 23(7):768-74. PubMed ID: 16842482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
    Chin BS; Futaba K; Jethwa A; Lip GY
    Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidaemia and coagulation defects of insulin resistance.
    Frohlich J; Steiner G
    Int J Clin Pract Suppl; 2000 Oct; (113):14-22. PubMed ID: 11965826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes: one disease, multiple cardiovascular risk factors.
    Calles-Escandon J; Garcia-Rubi E; Mirza S; Mortensen A
    Coron Artery Dis; 1999; 10(1):23-30. PubMed ID: 10196684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HRT and cardiovascular disease.
    Stevenson JC
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.